New President and CEO for Orion Corporation as of 1 January 2008
The Board of Directors of Orion Corporation has as of 1 January 2008 appointed M.Sc. (Eng.) Timo Lappalainen (b. 1962), who currently holds the position of Senior Vice President responsible for Orion's Proprietary Products and Animal Health business divisions, as the new President and CEO of the company and as the Chairman of the Executive Management Board of the Orion Group.
Mr. Lappalainen has joined Orion in 1999 as Senior Vice President, Business Development of Orion Pharma, also in charge of the business division's Finance and IT. In 2003 he was appointed Senior Vice President of the business division Orion Pharma with the responsibility of the human pharmaceuticals business. Since 2004 also the Animal Health business has belonged to his responsibilities. Since 2005 Mr. Lappalainen has been responsible for Orion's Proprietary Products and Animal Health businesses. Mr. Lappalainen has been a member of the Executive Management Board of the current Orion Group since its beginning, 1 July 2006. Before his career in Orion, Mr. Lappalainen has worked among others as a consultant with Arthur Andersen in the United States, as the Head of Business Development with Finvest Oy, and as a head of several functions with the pharmaceutical company Leiras Oy.
Most read news
Other news from the department people
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.